Login / Signup

A Universal Aptamer for Influenza A Viruses: Selection, Recognition, and Infection Inhibition.

Meng WangMeng-Chan HaoYueyue HuangfuKe-Zhu YangXiao-Qing ZhangYuan ZhangJianjun ChenZhi-Ling Zhang
Published in: ACS pharmacology & translational science (2023)
It is crucial to develop universal inhibitors for viral inhibition due to the rapid mutation of viruses. Herein, a universal aptamer inhibitor was developed that enabled a single DNA molecule to recognize several hemeagglutinin (HA) protein subtypes, inducing broad neutralization against influenza A viruses (IAVs). Through a multi-channel enrichment (MCE) strategy, a high-affinity aptamer named UHA-2 was obtained, with its dissociation constants ( K d ) for three different HA proteins being 1.5 ± 0.2 nM (H5N1), 3.7 ± 0.4 nM (H7N9), and 10.1 ± 1.1 nM (H9N2). The UHA-2 aptamer had a universal inhibition effect, by which it could broadly neutralize influenza A H5N1, H7N9, H9N2, H1N1, and H3N2 viruses. Universal aptamer inhibitors have the advantages of acquisition in vitro , stability, simple structure, small size, etc. This study not only develops a novel universal aptamer to achieve a broad inhibition effect on various IAVs, but also opens up an efficient strategy for the development of universal inhibitors against viruses.
Keyphrases
  • gold nanoparticles
  • sensitive detection
  • magnetic nanoparticles
  • label free
  • photodynamic therapy
  • genetic diversity
  • cell free
  • circulating tumor
  • binding protein
  • circulating tumor cells